BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23024775)

  • 1. Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women.
    Hasim A; Abudula M; Aimiduo R; Ma JQ; Jiao Z; Akula G; Wang T; Abudula A
    PLoS One; 2012; 7(9):e44952. PubMed ID: 23024775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.
    Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A
    Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of promoter methylation of ERp57 gene with the pathogenesis of cervical lesions in Uighur women].
    Abdula M; Abudulajiang G; Amiduo R; Abudala A; Hasim A
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):600-3. PubMed ID: 24314218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between TAP gene promoter methylation and cervical lesions with HPV infection in Uyghur women].
    Aikuer G; Jiao Z; Wu XC; Ma JQ; Abudla A; Hasim A
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):438-42. PubMed ID: 22932452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
    Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
    Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
    Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
    Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.
    Seliger B; Stoehr R; Handke D; Mueller A; Ferrone S; Wullich B; Tannapfel A; Hofstaedter F; Hartmann A
    Cancer Immunol Immunother; 2010 Apr; 59(4):529-40. PubMed ID: 19820934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
    Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
    Ritter C; Fan K; Paschen A; Reker Hardrup S; Ferrone S; Nghiem P; Ugurel S; Schrama D; Becker JC
    Sci Rep; 2017 May; 7(1):2290. PubMed ID: 28536458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between human papillomavirus type 16 infection and human leukocyte antigen class I expression in cervical cancers of Uighur women].
    Ma Q; Hasim A; Abudukadeer A; Yilike X; Wu GZ; Abudula A
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):255-8. PubMed ID: 20654125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.
    Cathro HP; Smolkin ME; Theodorescu D; Jo VY; Ferrone S; Frierson HF
    Cancer Immunol Immunother; 2010 Mar; 59(3):465-72. PubMed ID: 19756593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
    Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression.
    Liu Q; Hao C; Su P; Shi J
    Scand J Gastroenterol; 2009; 44(8):960-9. PubMed ID: 19492245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
    Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
    Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
    Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
    Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation of antigen processing machinery components and association with cervical carcinoma.
    Mehta AM; Jordanova ES; van Wezel T; Uh HW; Corver WE; Kwappenberg KM; Verduijn W; Kenter GG; van der Burg SH; Fleuren GJ
    Genes Chromosomes Cancer; 2007 Jun; 46(6):577-86. PubMed ID: 17366619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.
    Lazaridou MF; Gonschorek E; Massa C; Friedrich M; Handke D; Mueller A; Jasinski-Bergner S; Dummer R; Koelblinger P; Seliger B
    Oncoimmunology; 2020 Jun; 9(1):1774323. PubMed ID: 32923135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.